Physician profile
Peter H Chiu
NPI 1740338151
$2,562.86
in general payments reported to CMS, 2019-2025
15 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $247 · 2021: $537 · 2022: $264 · 2023: $330 · 2024: $414 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,027.64 | 2019-2025 | Repatha, Otezla, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $611.07 | 2022-2024 | Xifaxan, Trulance |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $144.63 | 2022-2025 | Cabtreo, Jublia |
| Amarin Pharma, INC. | $118.08 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.49 | 2020-2022 | |
| Radius Health, INC. | $113.02 | 2020-2025 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $101.14 | 2019-2025 | Breztri |
| Glaxosmithkline, LLC. | $82.70 | 2019-2021 | |
| Exact Sciences Corporation | $55.52 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $49.69 | 2021-2024 | Capvaxive, Gardasil 9, Gardasil |
| Sanofi Pasteur INC. | $41.79 | 2021-2025 | |
| Pfizer INC. | $38.91 | 2024 | |
| Astellas Pharma US INC | $24.37 | 2019 | |
| Abbvie INC. | $20.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.81 | 2023 | Strensiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.